HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis.

Abstract
Haemorrhagic cystitis is a common and often debilitating complication of chemotherapy for which treatment is frequently unsatisfactory. With over 80 cases reported of radiation-induced cystitis treated successfully with hyperbaric oxygen, attention is now turning to the treatment of chemotherapeutic agent-induced cystitis. We report a case of haemorrhagic cystitis occurring after autologous peripheral blood stem cell transplantation for multiple myeloma. The patient had received cyclophosphamide and busulfan and had BK and adenoviruria. The haemorrhage was refractory to multiple conventional treatments but resolved after a course of hyperbaric oxygen.
AuthorsA J Hughes, A P Schwarer, I L Millar
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 22 Issue 6 Pg. 585-6 (Sep 1998) ISSN: 0268-3369 [Print] England
PMID9758348 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide
  • Busulfan
Topics
  • Adenoviruses, Human (isolation & purification, pathogenicity)
  • Adult
  • Antineoplastic Agents, Alkylating (adverse effects)
  • BK Virus (isolation & purification, pathogenicity)
  • Busulfan (adverse effects)
  • Cyclophosphamide (adverse effects)
  • Cystitis (etiology, therapy)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Hemorrhage (etiology, therapy)
  • Humans
  • Hyperbaric Oxygenation
  • Male
  • Multiple Myeloma (therapy)
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: